Latest Breaking News On - Paul knoepfler - Page 4 : vimarsana.com

Is Cord-Blood Banking Worth It? - The Atlantic

FDA Official Pressured Via Text; More ADHD Telemed Scrutiny; PE Eyes Ophthalmology

This past week in healthcare investigations

Judge Rules in Favor of Stem Cell Clinic

Decision likely to be appealed, but could still have implications for FDA regulation

'The FDA Is Rarely That Clear': What We Heard This Week

Quotable quotes heard by <em>MedPage Today</em>'s reporters

FDA Getting Tougher on Birth Tissue Companies

Agency calls out manufacturer on orthopedic indications

Google relaxes ban on stem cell therapy ads

Google is relaxing its ban on ads for stem cell therapies and will allow ads from companies that have FDA approval. Stem cell treatments are often promoted by experimental clinics and can be dangerous.

Class action over unproven stem cell treatment settled for US$3.65 million

Stem cell clinic to pay out class action settlement

Lingering lawsuit over bogus claims from defunct La Jolla stem cell clinic settles for $3.65M

StemGenex, which went bankrupt in 2019, was sued for exaggerating customer satisfaction in its marketing for fat-derived cell treatments for multiple serious diseases.

Hiltzik: Stem cell clinic and doctor get a $3.65-million bill

StemGenex, a defunct La Jolla stem cell clinic, and a doctor reach a big class-action settlement.